June 21-22, 2023
ABOUT THE MEDINVEST ONCOLOGY INVESTOR CONFERENCE
The upcoming semiannual meeting of the MedInvest Oncology Investor Conference Series will be held on in Boston on June 21-22, 2023.
The conference will feature two days of company presentations, panel discussions, and keynote talks. Both in-person and virtual meetings will be taking place during the two days of the conference. The partnering system will be open for communications for one full month.
The presenting companies are developing and/or commercializing a broad spectrum of technologies, including those in Biotech, Pharmaceuticals, Diagnostics, Medical Device and Equipment, AI/Data Analytics, Precision Medicine, and others.
The event is the preeminent indication specific investor conference. The attendees are active investors in the oncology space and oncology-focused companies seeking investment.
The National Cancer Institute and Goodwin Procter Law Firm are the Presenting Partners. Oncology Investor Conference Series sponsors include Wilson Sonsini, McDermott Will & Emery, Perkins Coie, Cooley, Venable, Freemind Consultants, Torreya Partners and Marcum.
Join the leading life science and oncology venture capitalists, family offices, lawyers, pharma executives, private and public cancer companies and foundations for a discussion on trends, opportunities, and risks in oncology investing.